Pharmacotherapy of anxiety disorders: current and emerging treatment options A Garakani, JW Murrough, RC Freire, RP Thom, K Larkin, FD Buono, ... Frontiers in psychiatry, 1412, 2020 | 305 | 2020 |
The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1 FD Buono, ME Sprong, E Paul, S Martin, K Larkin, A Garakani Orphanet journal of rare diseases 16 (1), 1-8, 2021 | 14 | 2021 |
An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol A Garakani, RC Freire, FD Buono, RP Thom, K Larkin, MC Funaro, ... Plos one 17 (6), e0269772, 2022 | 6 | 2022 |
Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application FD Buono, C Lalloo, K Larkin, WT Zempsky, S Ball, LE Grau, Q Pham, ... Contemporary Clinical Trials Communications 25, 100883, 2022 | 6 | 2022 |
Parsing the effects of comorbid adult ADHD and substance misuse on affective lability in bipolar disorder A Garakani, FD Buono, K Larkin, JF Goldberg Journal of affective disorders 266, 338-340, 2020 | 6 | 2020 |
Patient requests for discharge from voluntary psychiatric hospitalization: a chart review A Garakani, JM Appel, AS Aloysi, JM Martinez, K Larkin, FD Buono Psychiatric Quarterly 90, 849-859, 2019 | 4 | 2019 |
Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid Misuse R Perry, E Elek, E D’Amico, D Dickerson, K Komro, M Walton, EB Razuri, ... Prevention Science, 1-16, 2023 | 2 | 2023 |
Perspectives on adapting a mobile application for pain self-management in neurofibromatosis type 1: results of online focus group discussions with individuals living with … LE Grau, K Larkin, C Lalloo, JN Stinson, WT Zempsky, SA Ball, FD Buono BMJ open 12 (7), e056692, 2022 | 2 | 2022 |
Development and validation of a new scale to measure chronic suicidal ideation: The chronic suicidal ideation Inventory-5 (CSI-5) A Garakani, FD Buono, K Larkin, M Polonsky, JF Goldberg Journal of Psychiatric Research, 2022 | 2 | 2022 |
Intensive Dialectical Behavior Treatment for Individuals With Borderline Personality Disorder With and Without Substance Use Disorders FD Buono, K Larkin, D Rowe, MM Perez-Rodriguez, ME Sprong, ... Frontiers in Psychology 12, 629842, 2021 | 2 | 2021 |
Impact of Childhood Trauma Histories Versus Recent Trauma Symptoms on Affective Lability in Adult Bipolar Disorder A Garakani, FD Buono, K Larkin, JF Goldberg The Journal of Clinical Psychiatry 82 (5), 36078, 2021 | 1 | 2021 |
Work readiness and barriers to employment during COVID-19 for individuals with neurofibromatosis Type 1 (NF1) FD Buono, M Polonsky, A Marks, K Larkin, ME Sprong Work, 1-9, 2023 | | 2023 |
Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF) FD Buono, K Larkin, Q Pham, D De Sousa, WT Zempsky, C Lalloo, ... Cancers 15 (12), 3213, 2023 | | 2023 |
Accelerated CREP-RRR: Turri, Buckwalter, & Blouw (2015) B Hall, J Wagge, G Pfuhl, S Stieger, E Vergauwe, H IJzerman, ED Musser, ... PsyArXiv, 2018 | | 2018 |